Monoclonal antibodies against β 3 integrins

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C424S130100, C424S141100, C424S143100, C424S144100, C424S173100, C435S007100, C435S334000, C435S343000, C435S346000, C530S387100, C530S388100, C530S388220, C530S388700

Reexamination Certificate

active

07731966

ABSTRACT:
Monoclonal antibodies prepared against platelet β3integrin useful in antithrombotic therapy or in models of thrombosis, thrombocytopenia, and anti-angiogenesis. The antibodies are prepared using β3integrin deficient (β3−/−) mice immunized against platelets or β3integrin fragments.

REFERENCES:
patent: 5766591 (1998-06-01), Brooks et al.
patent: 6951645 (2005-10-01), Ruan et al.
patent: WO01/21196 (2001-03-01), None
European Patent Office Extended European Search Report corresponding to European Patent Application No. 08153880.3-2402 dated Aug. 8, 2008.
International Search Report corresponding to International Application No. PCT/US00/26095 dated Jan. 9, 2001.
Mould, Paul A., et al., Evidence that monoclonal antibodies directed against the integrin beta subunit plexin/semaphorin/integrin domain stimulate function by inducing receptor extension.The Journal of Biological Chemistry. vol. 280, No. 6. pp. 4238-4246. (Feb. 2005).
Ni, H., et al., lntegrin activation by dithiothreitol or Mn2+ induces a ligand-occupied conformation and exposure of a novel NH2-terminal regulatory site on the beta1 integrin chain.The Journal of Biological Chemistry. vol. 273, No. 14. pp. 7981-7987. (Apr. 1998).
Peterson, Julie A., et al., A site involving the “hybrid” and PSI homology domains of GPIIIa (beta 3-integrin subunit) is a common target for antibodies associated with quinine-induced immune thrombocytopenia.Blood. vol. 101, No. 3. pp. 937-942. (Feb. 2003).
Xiao, Tsan, et al., Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics.Nature. vol. 432, No. 7013. pp. 59-67. (Nov. 2004).
Zhu, Guangheng, et al., Novel mouse anti-mouse beta 3 integrin monoclonal antibodies: Development, and characterization of new reagents for research in thrombosis and thrombocytopenia.Blood. vol. 110, No. 11. p. 627A. (Nov. 2007).
Beglova et al.,Cysteine-Rich Module Structure Reveals a Fulcrum for Integrin Rearrangement upon Activation. Nature Structural Biology. vol. 9, No. 4 pp. 282-287 (2002).
Behan, M.W.H and Storey, R.F.,Antiplatelet Therapy in Cardiovascular Disease. Postgrad. Med. J. vol. 80, pp. 155-164 (2004).
Bennett,Structure and Function of the Platelet Integrin αIIbβ3. The Journal of Clinical Investigation. vol. 115, No. 12 pp. 3363-3369 (2005).
Calvete, Juan,Minireview - Platelet Integrin GPIlb/Illa: Structure-Function Correlations. An Update and Lessons from Other Integrins. Platelet Integrin GPIIB/IIIA. pp. 29-38 (update to previously published paper in Proc. Soc. Exp. Biol. Med. 208:346-360, 1995).
Cluzel et al.,The Mechanisms and Dynamics of avβ3 Integrin Clustering in Living Cells. Journal of Cell Biology. vol. 171 pp. 383-392 (2005).
Filizola et al.,Mechanistic Insights from a Refined Three-Dimensional Model of Integrin αIIbβ3. The Journal of Biological Chemistry. vol. 279, No. 23 pp. 24624-24630 (2004).
Litvinov et al.,Multi-Step Fibrinogen Binding to the Integrin αIIbβ3Detected Using Force Spectroscopy. Biophysical Journal. vol. 89 pp. 2824-2834 (2005).
Ni et al.,A Novel Murine Model of Fetal and Neonatal Alloimmune Thrombocytopenia: Response to Intravenous IgG Therapy. Blood. vol. 107, No. 7 pp. 2976-2983 (2006).
Ni et al.,Persistence of Platelet Thrombus Formation in Arterioles of Mice Lacking Both von Willebrand Factor and Fibrinogen. The Journal of Clinical Investigation. vol. 106, No. 3 pp. 385-392 (2000).
Webster et al.,Relative efficacy of intravenous immunoglobin G in ameliorating thrombocytopenia induced by antiplatelet GPlIbIlla versus GPlbα antibodies. Blood. vol. 108, No. 3 pp. 943-946 (2006).
Yang et al.,Fibrinogen and von Willebrand Factor-Independent Platelet Aggregation In Vitro and In Vivo. Journal of Thrombosis and Haemostasis. vol. 4 pp. 2230-2237 (2006).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Monoclonal antibodies against β 3 integrins does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Monoclonal antibodies against β 3 integrins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monoclonal antibodies against β 3 integrins will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4177004

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.